Table 2.
SIV uptake (%) across all seasons 2011–2016 for 18–64 adults and 65+ adults, overall and stratified by sex, ethnicity, region, and at-risk conditions.
| Variable | 18–64 | 65+ |
|---|---|---|
| Overall | 35.3% | 74.0% |
| Sex | ||
| Male | 33.4% | 74.0% |
| Female | 37.1% | 74.0% |
| Ethnicity | ||
| Asian | 44.8% | 74.8% |
| Black | 34.5% | 64.3% |
| Mixed/Other | 36.3% | 76.2% |
| Unknown | 31.8% | 70.6% |
| White | 38.0% | 77.1% |
| PHE Region | ||
| London | 33.8% | 70.8% |
| Midlands & East | 36.0% | 74.7% |
| North | 36.8% | 76.3% |
| South | 34.8% | 73.6% |
| At-Risk Conditions | ||
| Pregnant | 39.8% | – |
| Chronic renal disease | 55.1% | 83.8% |
| Chronic heart disease | 52.7% | 84.0% |
| Chronic respiratory disease | 28.9% | 84.0% |
| Chronic liver disease | 41.3% | 79.0% |
| Diabetes | 69.5% | 85.0% |
| Immunosuppressed | 48.9% | 82.4% |
| Chronic neurological disease | 51.3% | 80.9% |
| Morbid obesity (BMI ≥ 40) | 27.2% | 76.5% |
(–) There were no pregnancy records among 65+ patients.